These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 18802720)

  • 1. Prevalence and determinants of non-adherence to topical hypotensive treatment in Dutch glaucoma patients.
    Olthoff CM; Hoevenaars JG; van den Borne BW; Webers CA; Schouten JS
    Graefes Arch Clin Exp Ophthalmol; 2009 Feb; 247(2):235-43. PubMed ID: 18802720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comprehensive perspective on patient adherence to topical glaucoma therapy.
    Tsai JC
    Ophthalmology; 2009 Nov; 116(11 Suppl):S30-6. PubMed ID: 19837258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of an eye drop guide to aid self-administration by patients experienced with topical use of glaucoma medication.
    Salyani A; Birt C
    Can J Ophthalmol; 2005 Apr; 40(2):170-4. PubMed ID: 16049530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multicenter study of compliance and drop administration in glaucoma.
    Kholdebarin R; Campbell RJ; Jin YP; Buys YM
    Can J Ophthalmol; 2008 Aug; 43(4):454-61. PubMed ID: 18711461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intentional and unintentional nonadherence to ocular hypotensive treatment in patients with glaucoma.
    Rees G; Leong O; Crowston JG; Lamoureux EL
    Ophthalmology; 2010 May; 117(5):903-8. PubMed ID: 20153902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Perception of glaucoma and therapeutic adherence: A multicenter observational study].
    Chiche A; Martin G; Brasnu de Cenival E; Rousseau A; Giocanti A; Fel A; Kallel S; Lombardi M; Hamard P; Baudouin C; Labbe A
    J Fr Ophtalmol; 2017 Jun; 40(6):477-486. PubMed ID: 28571839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Most Common Barriers to Glaucoma Medication Adherence: A Cross-Sectional Survey.
    Newman-Casey PA; Robin AL; Blachley T; Farris K; Heisler M; Resnicow K; Lee PP
    Ophthalmology; 2015 Jul; 122(7):1308-16. PubMed ID: 25912144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors Affecting Adherence to Topical Glaucoma Therapy: A Quantitative and Qualitative Pilot Study Analysis in Sydney, Australia.
    Spencer SKR; Shulruf B; McPherson ZE; Zhang H; Lee MB; Francis IC; Bank A; Coroneo MT; Agar A
    Ophthalmol Glaucoma; 2019; 2(2):86-93. PubMed ID: 32672609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of self-reported early glaucoma eye drop bottle exhaustion and associated risk factors: a patient survey.
    Moore DB; Walton C; Moeller KL; Slabaugh MA; Mudumbai RC; Chen PP
    BMC Ophthalmol; 2014 Jun; 14():79. PubMed ID: 24927769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adherence with topical glaucoma medication monitored electronically the Travatan Dosing Aid study.
    Okeke CO; Quigley HA; Jampel HD; Ying GS; Plyler RJ; Jiang Y; Friedman DS
    Ophthalmology; 2009 Feb; 116(2):191-9. PubMed ID: 19084273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and correlates of self-reported nonadherence with eye drop treatment: the Belgian Compliance Study in Ophthalmology (BCSO).
    Vandenbroeck S; De Geest S; Dobbels F; Fieuws S; Stalmans I; Zeyen T
    J Glaucoma; 2011 Sep; 20(7):414-21. PubMed ID: 21048510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electronic monitoring to assess adherence with once-daily glaucoma medications and risk factors for nonadherence: the automated dosing reminder study.
    Boland MV; Chang DS; Frazier T; Plyler R; Friedman DS
    JAMA Ophthalmol; 2014 Jul; 132(7):838-44. PubMed ID: 24830878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of eye drop administration technique in patients with glaucoma or ocular hypertension.
    Schwartz GF; Hollander DA; Williams JM
    Curr Med Res Opin; 2013 Nov; 29(11):1515-22. PubMed ID: 24006861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noncompliance with glaucoma medication in Korean patients: a multicenter qualitative study.
    Park MH; Kang KD; Moon J;
    Jpn J Ophthalmol; 2013 Jan; 57(1):47-56. PubMed ID: 23065047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Level of adherence to ocular hypotensive agents and its determinant factors among glaucoma patients in Menelik II Referral Hospital, Ethiopia.
    Mehari T; Giorgis AT; Shibeshi W
    BMC Ophthalmol; 2016 Aug; 16():131. PubMed ID: 27485739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between glaucoma medication adherence, eye drop technique, and visual field defect severity.
    Sleath B; Blalock S; Covert D; Stone JL; Skinner AC; Muir K; Robin AL
    Ophthalmology; 2011 Dec; 118(12):2398-402. PubMed ID: 21856009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Introduction: new insights on enhancing adherence to topical glaucoma medications.
    Friedman DS
    Ophthalmology; 2009 Nov; 116(11 Suppl):S29. PubMed ID: 19837257
    [No Abstract]   [Full Text] [Related]  

  • 18. Persistence and adherence with topical glaucoma therapy.
    Nordstrom BL; Friedman DS; Mozaffari E; Quigley HA; Walker AM
    Am J Ophthalmol; 2005 Oct; 140(4):598-606. PubMed ID: 16226511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A video study of drop instillation in both glaucoma and retina patients with visual impairment.
    Hennessy AL; Katz J; Covert D; Kelly CA; Suan EP; Speicher MA; Sund NJ; Robin AL
    Am J Ophthalmol; 2011 Dec; 152(6):982-8. PubMed ID: 21821228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Readability of prescription labels and medication recall in a population of tertiary referral glaucoma patients.
    O'Hare F; Jeganathan VS; Rokahr CG; Rogers SL; Crowston JG
    Clin Exp Ophthalmol; 2009 Dec; 37(9):849-54. PubMed ID: 20092593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.